Transcranial direct current stimulation enhances the efficacy of wearable transcutaneous electrical nerve stimulation for mild knee osteoarthritis in the middle-aged person: a randomized controlled trial
Objective To evaluate the efficacy of wearable transcutaneous electrical nerve stimulation (TENS) combined with transcranial direct current stimulation (tDCS) in the middle-aged person with mild knee osteoarthritis (KOA). Design Double-blind, randomized clinical trial. Setting A general hospital. Su...
Saved in:
Published in | BMC musculoskeletal disorders Vol. 26; no. 1; pp. 684 - 12 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
15.07.2025
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2474 1471-2474 |
DOI | 10.1186/s12891-025-08924-1 |
Cover
Summary: | Objective
To evaluate the efficacy of wearable transcutaneous electrical nerve stimulation (TENS) combined with transcranial direct current stimulation (tDCS) in the middle-aged person with mild knee osteoarthritis (KOA).
Design
Double-blind, randomized clinical trial.
Setting
A general hospital.
Subjects
Participants aged 60–70 with mild KOA (Kellgren–Lawrence grade 1–2).
Interventions
The experimental group received TENS + tDCS, and the control group received TENS + sham tDCS for four weeks from Monday through Friday.
Main measures
The primary outcome was Brief Pain Inventory (BPI). The secondary outcomes included participants’ Visual Analog Scale (VAS), step length, cadence, 6-minute walking test (6MWT), active knee range of motion (ROM), and quadriceps strength. The indexes were assessed one week before treatment (T0), two weeks after treatment commencement (T1), four weeks after treatment commencement (T2), one month after treatment cessation (T3), and two months after treatment cessation (T4).
Results
A total of 110 participants (55 per group) completed the intervention and follow-up. Repeated-measures ANOVA indicated that tDCS significantly improved the efficacy of TENS in alleviating pain and enhancing walking ability among patients with mild KOA. Statistically significant differences in BPI scores were observed between the experimental and control groups at T1 (2.16 vs. 2.45,
P
= 0.038), T2 (1.17 vs. 1.73,
P
< 0.001), and T3 (2.17 vs. 2.41,
P
= 0.021). However, no significant difference was detected at T4 (2.50 vs. 2.63,
P
= 0.293).
Conclusion
The four-week combined intervention demonstrated that tDCS potentiated the therapeutic efficacy of TENS in managing mild KOA. The combined protocol exhibited superiority over TENS monotherapy, with sustained benefits observed up to one-month post-intervention.
Trial registration
This research has been registered in chictr.org.cn (registration number: ChiCTR2200064735) on 15 October 2022,
https://www.chictr.org.cn/showproj.html?proj=182561
. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1471-2474 1471-2474 |
DOI: | 10.1186/s12891-025-08924-1 |